Avenue Therapeutics (ATXI) Misses Q1 EPS by 640c
Tweet
Share
E-mailGet Alerts ATXI Hot Sheet
Join SI Premium – FREE
Avenue Therapeutics (NASDAQ: ATXI) reported Q1 EPS of ($15.40), $6.40 worse than the analyst estimate of ($9.00).
For earnings history and earnings-related data on Avenue Therapeutics (ATXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Bureau Veritas agrees to sell oil and coal testing unit for €470M
- Freedom Broker Starts American States Water (AWR) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
